SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.38 -0.30
(-0.31%)

EUR-INR

110.93 -0.26
(-0.23%)

GBP-INR

128.32 -0.39
(-0.30%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

174.4719509

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

38.71

12293.97

EPS(TTM)

Face Value()

Div & Yield %

30.36

0.74

Back

apollo pipes ltd

Dr. Fresh Assets consolidated net profit rises 139.71% in the September 2025 quarter

Nov 16,2025

Net profit of Dr. Fresh Assets rose 139.71% to Rs 1.63 crore in the quarter ended September 2025 as against Rs 0.68 crore during the previous quarter ended September 2024. Sales rose 147.15% to Rs 4.77 crore in the quarter ended September 2025 as against Rs 1.93 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	4.77	1.93	147
OPM %	55.77	-4.66	-
PBDT	2.42	1.00	142
PBT	2.39	0.96	149
NP	1.63	0.68	140

77,328.19 -516.33 ( -0.66%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.38 -0.30 (-0.31%)

110.93 -0.26 (-0.23%)

128.32 -0.39 (-0.30%)

0.60 0.00 (-0.28%)